Holen Sie sich die Stockscreener-App
1.395
1.77%
-0.015
Schlusskurs vom Vortag:
$1.41
Offen:
$1.42
24-Stunden-Volumen:
534.86K
Relative Volume:
1.00
Marktkapitalisierung:
$155.24M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-24.22M
KGV:
-4.9839
EPS:
-0.2799
Netto-Cashflow:
$-17.13M
1W Leistung:
+13.52%
1M Leistung:
+42.67%
6M Leistung:
+28.24%
1J Leistung:
+70.99%
1-Tages-Spanne:
$1.33
$1.4496
1-Wochen-Bereich:
$1.2464
$1.48
52-Wochen-Spanne:
$0.7709
$1.59
Cardiol Therapeutics Inc Stock (CRDL) Company Profile
Compare CRDL vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CRDL
Cardiol Therapeutics Inc
|
1.39 | 157.47M | 0 | -24.22M | -17.13M | -0.2799 |
TAK
Takeda Pharmaceutical Co Adr
|
18.21 | 59.20B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
118.20 | 49.79B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.925 | 44.27B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.67 | 35.03B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
555.45 | 24.75B | 3.18B | 1.33B | 1.04B | 27.90 |
Cardiol Therapeutics Inc Stock (CRDL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-01-28 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-06-26 | Eingeleitet | ROTH MKM | Buy |
| 2024-04-22 | Eingeleitet | H.C. Wainwright | Buy |
Cardiol Therapeutics Inc Aktie (CRDL) Neueste Nachrichten
Cardiol Therapeutics (CRDL) Receives 'Buy' Rating from Canaccord Genuity | CRDL Stock News - gurufocus.com
Cardiol Therapeutics (NASDAQ:CRDL) Earns "Buy" Rating from Canaccord Genuity Group - MarketBeat
Cardiol Therapeutics (NASDAQ:CRDL) Raised to Hold at Wall Street Zen - MarketBeat
What is HC Wainwright's Estimate for CRDL FY2028 Earnings? - MarketBeat
CARDIOL THERAPEUTICS INC (CRDL.NE) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
CRDL Stock Price, Quote & Chart | CARDIOL THERAPEUTICS INC-A (NASDAQ:CRDL) - ChartMill
Merger Talk: Will Cardiol Therapeutics Inc outperform the market in YEAR2026 Analyst Calls & High Accuracy Investment Signals - baoquankhu1.vn
Cardiol surpasses 50% enrollment in phase III pericarditis trial By Investing.com - Investing.com Australia
Cardiol Therapeutics (NASDAQ:CRDL) Posts Earnings Results, Beats Expectations By $0.04 EPS - MarketBeat
Cardiol Therapeutics Details 2025 Progress and Funding for Late-Stage Cardiac Drug Programs - tipranks.com
Cardiol Therapeutics initiated pivotal Phase III Maveric trial of Cardiolrx in recurrent pericarditis - marketscreener.com
Cardiol Therapeutics Initiated Pivotal Phase Iii Maveric Trial Of Cardiolrx In Recurrent Pericarditis - TradingView
Cardiol surpasses 50% enrollment in phase III pericarditis trial - investing.com
Cardiol Therapeutics (NASDAQ: CRDL) advances 2025 cardiac trials and funding - Stock Titan
Heart drug trial passes halfway mark as Cardiol funds work into 2027 - Stock Titan
Cardiol Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Cardiol Therapeutics Achieves MAVERIC Enrollment Milestone Amidst Approaching Cash Runway Deadline - bitget.com
Cardiol Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Cardiol Therapeutics (CRDL) files Form 40-F: 100.26M shares, audited 2025 results - Stock Titan
Cardiol Therapeutics Inc expected to post a loss of 10 cents a shareEarnings Preview - TradingView
Fed Meeting: Can Cardiol Therapeutics Inc maintain its current growth rateWeekly Profit Recap & Technical Buy Zone Confirmation - baoquankhu1.vn
Cardiol Therapeutics (TSE:CRDL) Trading Up 10.5%Time to Buy? - MarketBeat
Earnings Recap: Can Cardiol Therapeutics Inc maintain its current growth rate2026 Analyst Calls & Community Consensus Trade Alerts - baoquankhu1.vn
Total debt of Cardiol Therapeutics Inc. Class A – HAM:CT9 - TradingView
Free cash flow of Cardiol Therapeutics Inc. Class A – HAM:CT9 - TradingView
Operating income of Cardiol Therapeutics Inc. Class A – HAM:CT9 - TradingView
Taxes of Cardiol Therapeutics Inc. Class A – HAM:CT9 - TradingView
Cardiol Therapeutics (CRDL) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
Cardiol Therapeutics (TSX:CRDL) Expands Research Scope In Tsx Small Cap Index - Kalkine Media
If You Invested $1,000 in Cardiol Therapeu (CRDL) - Stock Titan
Cardiol Therapeutics (TSE:CRDL) Shares Down 1.5%Time to Sell? - MarketBeat
CRDL SEC FilingsCardiol Therapeu 10-K, 10-Q, 8-K Forms - Stock Titan
Cizzle Brands Corporation Releases Fiscal Q2 2026 Results - Investing News Network
HC Wainwright & Co. Reiterates Cardiol Therapeutics (CRDL) Buy Recommendation - MSN
(CRDL) Trading Advice (CRDL:CA) - Stock Traders Daily
(CRDL) Optimized Trading Opportunities (CRDL:CA) - Stock Traders Daily
Cardiol Therapeutics Touts Phase III MAVERIC Timeline for CardiolRx at TD Cowen Healthcare Conference - MarketBeat
(CRDL) Stock Evaluation Report (CRDL:CA) - Stock Traders Daily
Cardiol Therapeutics (CRDL) Stock Analysis Report | Financials & Insights - Benzinga Japan
CRDL: Pivotal phase 3 data for CardiolRx in pericarditis expected late 2024, supporting broad expansion - TradingView
Cardiol Therapeutics (NASDAQ:CRDL) Shares Down 1%What's Next? - MarketBeat
(CRDL) Investment Performance Report (CRDL:CA)Stock Traders Daily Canada - Stock Traders Daily
Immix Biopharma to Participate in Upcoming Investor Conferences - Investing News Network
Aug Highlights: Should you avoid Cardiol Therapeutics Inc stock right nowPortfolio Performance Report & High Accuracy Swing Entry Alerts - baoquankhu1.vn
(CRDL) Market Insights and Trading Signals (CRDL:CA) - Stock Traders Daily
Cardiol Therapeutics (TSE:CRDL) Trading Down 4.8%Time to Sell? - MarketBeat
Cardiol Therapeutics to Present Cardiovascular Pipeline Update at TD Cowen Health Care Conference - TipRanks
Cardiol Therapeutics (NASDAQ: CRDL) outlines heart programs at TD Cowen - Stock Titan
Cardiol Therapeutics to Present at TD Cowen 46th Annual Health Care Conference - TMX Newsfile
Objective long/short (CRDL) Report (CRDL:CA) - Stock Traders Daily
argenx to Present at TD Cowen 46th Annual Healthcare Conference - Investing News Network
Finanzdaten der Cardiol Therapeutics Inc-Aktie (CRDL)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):